HRT Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.43M Buy
+577,337
New +$2.23M ﹤0.01% 1617
2025
Q4
Sell
-39,844
Closed -$52K 3582
2025
Q3
$52K Buy
+39,844
New +$41.2K ﹤0.01% 2601
2024
Q3
Sell
-60,271
Closed -$392K 2769
2024
Q2
$392K Buy
+60,271
New +$426K ﹤0.01% 1403
2024
Q1
Sell
-189,276
Closed -$2.17M 2674
2023
Q4
$2.17M Sell
189,276
-52,761
-22% -$522K 0.02% 618
2023
Q3
$2.33M Buy
242,037
+42,292
+21% +$414K 0.02% 556
2023
Q2
$2.13M Buy
199,745
+61,578
+45% +$662K 0.02% 588
2023
Q1
$1.45M Sell
138,167
-183,662
-57% -$2.06M 0.02% 761
2022
Q4
$3.99M Sell
321,829
-355,404
-52% -$4.03M 0.06% 326
2022
Q3
$7.02M Buy
+677,233
New +$7.68M 0.08% 208
2021
Q4
Sell
-53,077
Closed -$693K 3606
2021
Q3
$693K Sell
53,077
-26,107
-33% -$337K ﹤0.01% 1713
2021
Q2
$1.02M Buy
+79,184
New +$906K 0.01% 1064
2021
Q1
Sell
-15,086
Closed -$171K 2895
2020
Q4
$171K Buy
+15,086
New +$165K ﹤0.01% 1532
2019
Q4
Sell
-12,651
Closed -$108K 1390
2019
Q3
$108K Buy
+12,651
New +$123K 0.01% 1237

Other funds holding IRWD

HRT Financial's IRWD Position: Q2 2026 in Review

HRT Financial opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 577,337 shares worth $2.43M. The stake represents ﹤0.01% of the portfolio and ranks #1617 among its holdings. This is a return to the name: HRT Financial previously reported a position in IRWD as recently as Q3 2025.

HRT Financial first reported a position in IRWD in Q3 2019 and has held it in 13 quarters since. The position peaked at $7.02M in Q3 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • HRT Financial held 577,337 shares of Ironwood Pharmaceuticals worth $2.43M as of Q2 2026.
  • Ironwood Pharmaceuticals was a new HRT Financial position in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1617 holding.
  • HRT Financial first reported a position in Ironwood Pharmaceuticals in Q3 2019 and has held it in 13 quarters since.
  • HRT Financial's Ironwood Pharmaceuticals position peaked at $7.02M in Q3 2022.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.